Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Migraine Drug Developer Raises $82.5M in IPO

NASDAQ share price display

A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Hearing Loss Cell Therapy Licensed in $625M Deal

Man with headphones

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal

Stem Cell Start-Up Raises $250M in Venture Funds

T-cell lymphocyte

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

Genetic Risk Analysis Shows Ethnic Bias

DNA puzzle

Techniques analyzing data from across the genome that reveal risks of diseases, better predict disorders in the main ethnicity of the population studied than other ethnic groups. . . . → Read More: Genetic Risk Analysis Shows Ethnic Bias

Designing Strawberry Varieties for Japanese Farms

Strawberries

An agricultural genomics company in Israel and auto maker Toyota began a joint project to design new varieties of strawberries to grow on Japanese farms . . . → Read More: Designing Strawberry Varieties for Japanese Farms

Robotics, A.I. Employed for Personal Autism Therapy

Nao robot

An engineering lab at MIT developed techniques for combining robotics with deep learning, a form of artificial intelligence, to personalize autism therapy. . . . → Read More: Robotics, A.I. Employed for Personal Autism Therapy

Large-Scale Process Devised for Lab-Made Liver Tissue

Researchers in Japan and the U.S. created techniques for producing liver tissue in large quantities in the lab for transplant or drug testing. . . . → Read More: Large-Scale Process Devised for Lab-Made Liver Tissue

Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies. . . . → Read More: Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Takeda, Biosurfaces Partner on Nanofiber Devices

Takeda Pharmaceutical Company is joining with a developer of medical devices from nanoscale bioactive fibers to design new devices for gastrointestinal, or GI, disorders. . . . → Read More: Takeda, Biosurfaces Partner on Nanofiber Devices